Rapid Clinical Updates: From Gas Station Shelf to Hospital Bed: Managing Kratom and 7-OH Toxicity and Withdrawal-Handout

Pdf Summary

<strong>Summary: Kratom and 7-OH Substances</strong>

Kratom is a Southeast Asian herbal product now widely available in the U.S., often sold over the counter as capsules or powder. Its main alkaloids, <strong>mitragynine</strong> and <strong>hydroxymitragynine</strong>, act as mixed opioid receptor agonists/antagonists. <strong>7-OH substances</strong> are kratom-derived alkaloids that may also be synthesized into stronger products. Availability and regulation vary by state and are likely to change.

Although kratom is sometimes marketed for pain relief, mental health symptoms, or opioid reduction, it can cause important adverse effects. Mild toxicity may present with <strong>agitation, tachycardia, and confusion</strong>. More serious effects include <strong>seizures, withdrawal, hallucinations, respiratory depression, coma, and cardiac or respiratory arrest</strong>. These products are often used with other substances, which can worsen outcomes.

A key pitfall is that kratom use may mimic <strong>opioid withdrawal</strong> but usually does <strong>not appear on standard urine toxicology screens</strong>. Because labeling can be misleading, clinicians should specifically ask about kratom and related product use, especially when polysubstance use is suspected.

Treatment is guided by opioid-withdrawal principles. <strong>Buprenorphine</strong> is the preferred evidence-based therapy. The <strong>COWS score</strong> can help determine when to start treatment, typically when symptoms are in the <strong>8–13</strong> range. If <strong>precipitated withdrawal</strong> occurs, more buprenorphine may be needed until COWS returns to about 8. <strong>Methadone may need to be stopped after discharge</strong>, and <strong>naltrexone is not recommended in the acute hospital setting</strong> due to lack of evidence.

Hospitalization is an opportunity to identify use, educate patients about risks, and provide discharge counseling and referral resources.

Meta Tag

Concept Kratom

Concept 7-Hydroxymitragynine

Concept Opioid Toxicity

Concept Respiratory Depression

Concept Opioid Receptor

Keywords

kratom

7-OH substances

mitragynine

hydroxymitragynine

opioid receptor agonist

opioid withdrawal

buprenorphine

COWS score

precipitated withdrawal

urine toxicology screen

Kratom

7-Hydroxymitragynine

Opioid Toxicity

Respiratory Depression

Opioid Receptor